To the best of our knowledge, this is the first meta-analysis to demonstrate the prognostic significance of mTOR/p-mTOR expression and its relationship to the clinicopathological characteristics of ESCC. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.